Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): Retrospective cohort study

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1150-1155

  Hiba, Vered ^a   Chowers, Michal ^a,b   Levi Vinograd, Inbal ^a   Rubinovitch, Bina ^a,c   Leibovici, Leonard ^a,c   Paul, Mical ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Antivirals; Flu; Influenza related complications; Neuraminidase inhibitors; Viral pneumonia

Indexed keywords

OSELTAMIVIR; SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; FEMALE; HEMODYNAMICS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPOXIA; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; RETROSPECTIVE STUDY; RHINORRHEA; RISK FACTOR; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE; ISRAEL; MALE; MIDDLE AGED; OSELTAMIVIR; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79954618349     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr089     Document Type: Article

References (18)

1. Jefferson T, Jones M, Doshi P et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009; 339: b5106.
2. Jefferson T, Jones M, Doshi P et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2010; issue 2: CD001265.
3. Davies A, Jones D, Bailey M et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888-95.
4. Dominguez-Cherit G, Lapinsky SE, Macias AE et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302: 1880-7.
5. Kumar A, Zarychanski R, Pinto R et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302: 1872-9.
6. Louie JK, Acosta M, Winter K et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896-902.
7. Mendelson E, Mandelboim M, Grossman Z et al. [Laboratory diagnosis of influenza H1N1 2009 at the Central Virology Laboratory in Israel during the first 12 weeks of the pandemic]. Harefuah 2009; 148: 677-81, 735.
8. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007; 16: 241-9.
9. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007; 16: 219-42.
10. Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-44.
11. Yu H, Feng Z, Uyeki TM et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011; 52: 457-65.
12. Yu H, Liao Q, Yuan Y et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010; 341: c4779.
13. Fuhrman C, Bonmarin I, Paty AC et al. Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill 2010; 15: pii=19463.
14. Cao B, Li XW, Mao Y et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361: 2507-17.
15. Li IW, Hung IF, To KK et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137: 759-68.
16. Ling LM, Chow AL, Lye DC et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50: 963-9.
17. Na S, Chong YP, Kim MN et al. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection. J Med Virol 2010; 83: 5-9.
18. Toovey S, Rayner C, Prinssen E et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008; 31: 1097-114.